KKR Genetic Disorder L.P.
BridgeBio Pharma, Inc. - Common Stock · 10% Owner
KKR Genetic Disorder L.P. is listed in public filings as 10 percent owner. This KKR Genetic Disorder L.P. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include BridgeBio Pharma, Inc. - Common Stock (BBIO). Investors use KKR Genetic Disorder L.P.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $454M13.3M shares | SellMay 12, 2025 | $205.2M6M shares | $34.20 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| Historical actions before the latest disclosure date will appear here after more snapshots are available. | |||||